Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 354,296 shares of Cosmos Health stock in a transaction that occurred on Monday, February 24th. The stock was purchased at an average cost of $0.56 per share, for a total transaction of $198,405.76. Following the completion of the transaction, the chief executive officer now directly owns 3,897,016 shares in the company, valued at $2,182,328.96. This trade represents a 10.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Thursday, January 30th, Grigorios Siokas purchased 51,414 shares of Cosmos Health stock. The stock was acquired at an average price of $0.66 per share, for a total transaction of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas acquired 38,900 shares of Cosmos Health stock. The shares were acquired at an average price of $0.77 per share, with a total value of $29,953.00.
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were bought at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The stock was bought at an average cost of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas acquired 163,666 shares of Cosmos Health stock. The shares were bought at an average price of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were bought at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Down 4.6 %
Shares of NASDAQ:COSM opened at $0.54 on Friday. The business’s 50 day moving average is $0.69 and its 200 day moving average is $0.81. The stock has a market cap of $12.54 million, a P/E ratio of -0.22 and a beta of 5.56. Cosmos Health Inc. has a 52-week low of $0.47 and a 52-week high of $1.58. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08.
Hedge Funds Weigh In On Cosmos Health
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- ESG Stocks, What Investors Should Know
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Find and Profitably Trade Stocks at 52-Week Lows
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.